Skip to content

Clinical trials

Hyperlipoproteinemia Type II trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipoproteinemia Type II Country / region: Brazil Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20121
20161
20233
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospital do Coracao3
Amgen2
Kastle Therapeutics, LLC2
Novartis Pharmaceuticals2
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipoproteinemia Type II10
Hypercholesterolemia6
Homozygous Familial Hypercholesterolemia5
Dyslipidemias3
Hyperlipidemias3
Congenital Abnormalities2
Genetic Diseases, Inborn2
Hyperlipoproteinemias2
Infant, Newborn, Diseases2
Lipid Metabolism Disorders2

Trials

Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.